title: [Impact of the new screening criteria on the gestational diabetes prevalence].
abstract: BACKGROUND
  To evaluate the impact of the new IADPSG thresholds on gestational diabetes mellitus (GDM) prevalence.
  
  
  METHODS
  Universal screening for GDM was performed in 200 consecutive patients at 24 to 28 weeks with 75 g oral glucose tolerance test.
  
  
  RESULTS
  The prevalence of GDM was 14.0%. We observed that among the 28 patients with GDM, 16 (57.1%) had only one abnormal value, 10 (35.7%) two abnormal values and only two (7.2%) had three abnormal values. For the 16 patients with one abnormal value, 13 of them (81.2%) have an abnormal fasting plasma glucose (FPG). Patients with GDM had an increased body mass index (29.6 kg/m(2) vs 25.1 kg/m(2), P<0.001) and more important rates of familial history of type II diabetes (46.4% vs 21.5%, P<0.005) and history of GDM in a previous pregnancy (21.4% vs 2.9%, P<0.002) compared to non-GDM patients. Birth weight was increased in offspring of mothers with GDM (3451.3g vs 3387.4 g, P<0.05).
  
  
  CONCLUSIONS
  Our study found an increased rate of GDM with the new IADPSG criteria compared to previous published data. Higher rates of GDM represent a challenge for the organization of perinatal teams involved in GDM care.
authors: Pôle femme, mère, nouveau-né, clinique d'obstétrique, maternité Jeanne-de-Flandre, CHRU de Lille, 59037 Lille, France.
authors: E
authors: E
authors: Wery
authors: Pôle d'endocrinologie-diabétologie, hôpital Claude-Huriez, CHRU de Lille, 59037 Lille, France; EA 4489, environnement périnatal et croissance, faculté de médecine Henri-Warembourg, université Lille 2, 59045 Lille, France.
authors: A
authors: A
authors: Vambergue
authors: Maternité Paul-Gellé, centre hospitalier de Roubaix, 59100 Roubaix, France.
authors: F
authors: F
authors: Le Goueff
authors: Maternité Paul-Gellé, centre hospitalier de Roubaix, 59100 Roubaix, France.
authors: D
authors: D
authors: Vincent
authors: Pôle femme, mère, nouveau-né, clinique d'obstétrique, maternité Jeanne-de-Flandre, CHRU de Lille, 59037 Lille, France; EA 4489, environnement périnatal et croissance, faculté de médecine Henri-Warembourg, université Lille 2, 59045 Lille, France. Electronic address: philippe.deruelle@univ-lille2.fr.
authors: P
authors: P
authors: Deruelle
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics; D016640:Diabetes, Gestational / Q000175:diagnosis / Q000453:epidemiology*; D005215:Fasting; D005260:Female; D005602:France; D005865:Gestational Age; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D011247:Pregnancy; D011446:Prospective Studies; D012008:Recurrence
chemical_list: D001786:Blood Glucose
keywords: Diabète gestationnel; Dépistage; Gestational diabetes; Guidelines; HAPO study; IADPSG; Recommandations; Screening; Étude HAPO